Your browser doesn't support javascript.
loading
Discovery of Potent EGFR Inhibitors With 6-Arylureido-4-anilinoquinazoline Derivatives.
Li, Meng; Xue, Na; Liu, Xingang; Wang, Qiaoyun; Yan, Hongyi; Liu, Yifan; Wang, Lei; Shi, Xiaowei; Cao, Deying; Zhang, Kai; Zhang, Yang.
Afiliação
  • Li M; Department of Medicinal Chemistry, Hebei Medical University, Shijiazhuang, China.
  • Xue N; Department of Pharmaceutical Engineering, Hebei Chemical and Pharmaceutical College, Shijiazhuang, China.
  • Liu X; Department of Medicinal Chemistry, Hebei Medical University, Shijiazhuang, China.
  • Wang Q; Department of Medicinal Chemistry, Hebei Medical University, Shijiazhuang, China.
  • Yan H; Department of Medicinal Chemistry, Hebei Medical University, Shijiazhuang, China.
  • Liu Y; Department of Medicinal Chemistry, Hebei Medical University, Shijiazhuang, China.
  • Wang L; Department of Medicinal Chemistry, Hebei Medical University, Shijiazhuang, China.
  • Shi X; Department of Medicinal Chemistry, Hebei Medical University, Shijiazhuang, China.
  • Cao D; Department of Medicinal Chemistry, Hebei Medical University, Shijiazhuang, China.
  • Zhang K; Department of Medicinal Chemistry, Hebei Medical University, Shijiazhuang, China.
  • Zhang Y; Department of Medicinal Chemistry, Hebei Medical University, Shijiazhuang, China.
Front Pharmacol ; 12: 647591, 2021.
Article em En | MEDLINE | ID: mdl-34122069
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Suíça